glp-1 drugs and dementia Role of glucagon-like peptide-1 receptor agonists in Alzheimer's disease Parkinson's disease | Journal of Biomedical Science Alzheimer's: Ozempic and Similar Drugs

However, sacubitril failed to inhibit the functional LVDP recovery observed with GLP-1 in our ex vivo model of IRI

Already, many GLP-1 users quit within a year, studies suggest -- often due to side effects, high costs, or insurance issues

Journal reference: Xie Y, Choi T, Al-Aly Z (2026)

Were doing it because different brand names of the same generic medication have been approved for different indications, so we dont want to cause confusion

GLP-1 (glucagon-like peptide-1) receptor agonists are medications used primarily to treat type 2 diabetes and support weight loss

39 Mindful Eating: Savoring the Journey Mindful eating involves paying full attention to the eating experiencebeing present with the food, eating slowly, savoring tastes and textures, and minimizing distractions like screens or working while eating